This year’s winner of the American Association for Cancer Research (AACR) Award for Outstanding Achievement in Chemistry in Cancer Research is Vanderbilt University Professor Stephen Fesik. He delivered his award lecture on Drugging the Undruggable Using Fragment-Based Methods at the AACR’s annual meeting in Chicago.
Chemical manufacturer Ash Stevens sponsored the Award.
Dr Stephen Munk, chief executive of Ash Stevens, said: ‘We are proud to be the sponsor of this well-earned award. Stephen Fesik’s early use of nuclear magnetic resonance has and will continue to play a vital part in the prevention of cancer and the treatment of patients with cancer. Professor Fesik’s studies are proof of the global scope of the cancer research team.’
Ash Stevens played a key role in securing from the US FDA fast-track approval for Active Pharmaceutical Ingredients in oncology.
